The Protein Study

We are conducting a clinical trial to evaluate a new investigational treatment in participants without any known medical condition. This study aims to assess the safety, tolerability, and how the body processes the medication under different conditions, including variations in food intake and age.

The investigational treatment is being developed as a potential future therapy for conditions involving abnormal protein stability and organ health, including AL amyloidosis. This is the first step before testing its effectiveness in patients.

Call us on 1300 681 951 to discuss your eligibility today!